Lattice Biologics LBLTF Stock
Lattice Biologics Price Chart
Lattice Biologics LBLTF Financial and Trading Overview
| Lattice Biologics stock price | 0.0001 USD |
| Previous Close | 0.0001 USD |
| Open | 0.0001 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.0001 - 0.0001 USD |
| 52 Week Range | 0.0001 - 0.02 USD |
| Volume | 107K USD |
| Avg. Volume | 1.7K USD |
| Market Cap | 4.07M USD |
| Beta (5Y Monthly) | -8.826358 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
LBLTF Valuation Measures
| Enterprise Value | 12.82K USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.61012 |
| Price/Book (mrq) | 0.099999994 |
| Enterprise Value/Revenue | 0.008 |
| Enterprise Value/EBITDA | -0.048 |
Trading Information
Lattice Biologics Stock Price History
| Beta (5Y Monthly) | -8.826358 |
| 52-Week Change | -99.44% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.02 USD |
| 52 Week Low | 0.0001 USD |
| 50-Day Moving Average | 0.0001 USD |
| 200-Day Moving Average | 0.000458 USD |
LBLTF Share Statistics
| Avg. Volume (3 month) | 1.7K USD |
| Avg. Daily Volume (10-Days) | 10.7K USD |
| Shares Outstanding | 128.22M |
| Float | 84.18M |
| Short Ratio | N/A |
| % Held by Insiders | 2.31% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:3 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | September 30, 2020 |
| Most Recent Quarter (mrq) | June 30, 2021 |
| Next Fiscal Year End | September 30, 2021 |
Profitability
| Profit Margin | -61.081% |
| Operating Margin (ttm) | -39.52% |
| Gross Margin | 41.43% |
| EBITDA Margin | -16.99% |
Management Effectiveness
| Return on Assets (ttm) | -24.94% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 1.56M USD |
| Revenue Per Share (ttm) | 0.01 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 1.18M USD |
| EBITDA | -264731 USD |
| Net Income Avi to Common (ttm) | -951653 USD |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | 0.001 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -132009 USD |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Lattice Biologics
| Country | United States |
| State | MT |
| City | Belgrade |
| Address | 512 East Madison Avenue |
| ZIP | 59714 |
| Phone | N/A |
| Website | N/A |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Lattice Biologics Ltd., a biotech company, develops, manufactures, and markets biologics products for use in the field of bone regeneration in dental, spine, and general orthopedic indications worldwide. It develops acellular demineralized bone scaffold, a human cortical bone demineralized that are used in various applications in orthopedic, neurological, trauma, oral/maxillofacial, and reconstructive procedures; and acellular dermal matrix that provides a natural collagen tissue scaffold that promotes cellular ingrowth, tissue vascularization, and regeneration The company also develops amniotic fluid-based products, such as AmnioBoost and AmnioBlast. In addition, it sells traditional allografts for multi-disciplinary applications, including orthopedics, neurology, podiatry, and oral/maxillofacial. The company was founded in 2013 and is headquartered in Belgrade, Montana.
Q&A For Lattice Biologics Stock
What is a current LBLTF stock price?
Lattice Biologics LBLTF stock price today per share is 0.0001 USD.
How to purchase Lattice Biologics stock?
You can buy LBLTF shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Lattice Biologics?
The stock symbol or ticker of Lattice Biologics is LBLTF.
Which industry does the Lattice Biologics company belong to?
The Lattice Biologics industry is Medical Devices.
How many shares does Lattice Biologics have in circulation?
The max supply of Lattice Biologics shares is 40.67B.
What is Lattice Biologics Price to Earnings Ratio (PE Ratio)?
Lattice Biologics PE Ratio is now.
What was Lattice Biologics earnings per share over the trailing 12 months (TTM)?
Lattice Biologics EPS is -0.01 USD over the trailing 12 months.
Which sector does the Lattice Biologics company belong to?
The Lattice Biologics sector is Healthcare.